Cargando…

Improvement of Post Stroke Echolalia after Using Selective Serotonin Reuptake Inhibitors

Detalles Bibliográficos
Autores principales:	Bae, Heewon, Park, JaeYoung, Yang, YoungSoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Dementia Association 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494782/ https://www.ncbi.nlm.nih.gov/pubmed/31097970 http://dx.doi.org/10.12779/dnd.2019.18.1.30

Ejemplares similares

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Repurposing Selective Serotonin Reuptake Inhibitors for COVID-19: Rationale and Concerns
por: Navin, Karthick, et al.
Publicado: (2020)

Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: author's response
por: Deng, Jiawen, et al.
Publicado: (2023)

Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination
por: Praharaj, Samir Kumar
Publicado: (2011)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Hypothalamic‐related neural mechanism in lifelong premature ejaculation and trends following selective serotonin reuptake inhibitor administration
por: Geng, Bowen, et al.
Publicado: (2022)

In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Yi, Julie, et al.
Publicado: (2022)

Rapid response to selective serotonin reuptake inhibitors in post-COVID depression
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Selective Serotonin Reuptake Inhibitors for the Prevention of Post-Stroke Depression: A Systematic Review and Meta-Analysis
por: Richter, Daniel, et al.
Publicado: (2021)

Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al.
por: Zeng, Guangting, et al.
Publicado: (2023)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors
por: POP, ANCA, et al.
Publicado: (2015)

Prestroke selective serotonin reuptake inhibitor use and functional outcomes after ischaemic stroke
por: Etherton, Mark R, et al.
Publicado: (2018)

Echolalia from a transdiagnostic perspective
por: McFayden, Tyler C, et al.
Publicado: (2022)

Echolalia as defined by parent communication partners
por: Cohn, Eli G, et al.
Publicado: (2023)

Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link
por: Patel, Harish, et al.
Publicado: (2015)

Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence
por: Siepmann, Timo, et al.
Publicado: (2015)

Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke: A meta-analysis
por: Zhou, Shaojiong, et al.
Publicado: (2020)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment
por: Alexeev, Vasiliy Grigorievich, et al.
Publicado: (2011)

Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
por: Diav-Citrin, Orna, et al.
Publicado: (2012)

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
por: Kobayashi, Katsunori, et al.
Publicado: (2011)

Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation
por: Jury, Nicholas J., et al.
Publicado: (2015)

Selective Serotonin–norepinephrine Reuptake Inhibitors-induced Takotsubo Cardiomyopathy
por: Vasudev, Rahul, et al.
Publicado: (2016)

Ankle edema after administration of selective serotonin reuptake inhibitors
por: Kontoangelos, Konstantinos, et al.
Publicado: (2018)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
por: Nguyen, Thanh Thanh L., et al.
Publicado: (2021)

Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Jannini, Tommaso B., et al.
Publicado: (2022)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19
por: Sidky, Hythem, et al.
Publicado: (2023)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Hyperkinesias and Echolalia in Primary Familial Brain Calcification
por: Paucar, Martin, et al.
Publicado: (2020)

Comparison of Treatment Adherence between Selective Serotonin Reuptake Inhibitors and Moclobemide in Patients with Social Anxiety Disorder
por: Lim, Se-Won, et al.
Publicado: (2012)

Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis
por: Sassano-Higgins, Sean A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_83pibbujirn8uo3gt6f895r1dm